fatty acid binding protein 7 pseudogene 2Genealiases: []
Q-omics provides the consensus-scored FABP7P2 profile across patient tissues and cancer cell-line models. FABP7P2 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, FABP7P2 is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, FABP7P2 RNA expression shows 8,707 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight BLCA, THCA, and UVM as cancer lineages where FABP7P2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for FABP7P2 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes FABP7P2 survival associations across molecular data types. FABP7P2 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible FABP7P2 RNA expression–survival associations across cancer types. High FABP7P2 expression shows unfavorable associations in BLCA, LUSC, CHOL, BRCA and MESO, but favorable associations in ACC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for FABP7P2 RNA expression.
This table summarizes FABP7P2 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for FABP7P2. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. FABP7P2 shows lower tumor expression in THCA. The THCA box plot shows higher FABP7P2 RNA expression in normal versus tumor tissue (log2 FC = −0.211, t-test p < 0.001).
This table shows molecular features associated with FABP7P2 in patient tissues and cancer cell lines. In patient samples, FABP7P2 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
